![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Multiple Sclerosis |
|
Free Subscription
1 Ann Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
Genetic-Proteomic Integration Identifies Predictive Plasma Proteins for Multiple
Sclerosis.
Ann Neurol. 2026 May 22. doi: 10.1002/ana.78256.
PubMed
Abstract available
Does depressed mood affect accuracy of perceptions of cognitive function in
multiple sclerosis? The role of momentary depressive symptoms in the
correspondence between subjective and objective cognition in multiple sclerosis.
Arch Phys Med Rehabil. 2026 May 17:S0003-9993(26)00729.
PubMed
Abstract available
Translingual neural stimulation to improve gait and balance in multiple
sclerosis: A randomized controlled trial.
Arch Phys Med Rehabil. 2026 May 17:S0003-9993(26)00706.
PubMed
Abstract available
Efficacy of transcranial direct current stimulation on motor and cognitive
functions in patients with multiple sclerosis: a systematic review and
meta-analysis.
BMC Neurol. 2026 May 15. doi: 10.1186/s12883-026-04961.
PubMed
Abstract available
Acute Effects of Virtual Reality-Based Optokinetic Stimulation: Comparison of
Individuals with Multiple Sclerosis With and Without Central Vestibular
Dysfunction.
Can J Neurol Sci. 2026 May 22:1-33. doi: 10.1017/cjn.2026.10622.
PubMed
Identification of an immunogenic epitope from RASGRP2 with specificity for
HLA-DR15 in multiple sclerosis.
J Neuroimmunol. 2026;418:578971.
PubMed
Abstract available
Late-onset multiple sclerosis is associated with relapse-independent disability
accrual: a propensity score-weighted recurrent-event study.
J Neurol. 2026;273:332.
PubMed
Abstract available
Increased functional network connectivity following cognitive rehabilitation in
progressive multiple sclerosis with moderate to severe disabilty: findings from
the CogEx study.
J Neurol. 2026;273:325.
PubMed
Abstract available
Trajectories of processing speed in multiple sclerosis across disease-modifying
therapies.
J Neurol. 2026;273:324.
PubMed
Abstract available
Correction: Ozone pollution as a possible trigger for multiple sclerosis in young
people: the PEDIGREE study.
J Neurol. 2026;273:319.
PubMed
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple
sclerosis: a multi-registry observational cohort study.
J Neurol Neurosurg Psychiatry. 2026 May 20:jnnp-2026-338424.
PubMed
Abstract available
Seeing the unseen in multiple sclerosis: From reactive care to anticipatory
medicine.
J Neurol Sci. 2026;487:126009.
PubMed
No evidence for a causal link between plasma lipids and multiple sclerosis
susceptibility and severity: A Mendelian randomisation study.
J Neurol Sci. 2026;487:125986.
PubMed
Abstract available
Comment on "A proof-of-concept study on the relationship between lifetime
Estrogen exposure, menopausal transition, and neurodegeneration in women with
multiple sclerosis".
J Neurol Sci. 2026;487:125962.
PubMed
Transcranial magnetic stimulation in multiple sclerosis: Targeting symptoms
through neuroplasticity.
Mult Scler. 2026 May 19:13524585261442777. doi: 10.1177/13524585261442777.
PubMed
Abstract available
Impact of adverse childhood experiences on long-term quality of life in adults
with pediatric-onset multiple sclerosis.
Mult Scler. 2026 May 20:13524585261444237. doi: 10.1177/13524585261444237.
PubMed
Abstract available
Rethinking prognosis in multiple sclerosis: a multiaxial perspective.
Nat Rev Neurol. 2026 May 19. doi: 10.1038/s41582-026-01212.
PubMed
Abstract available
Decoding the genetic basis of demyelination: Prediction of potential pathogenic
coding and regulatory noncoding MBP SNPs in multiple sclerosis.
PLoS One. 2026;21:e0347598.
PubMed
Abstract available
Thank you for your interest in scientific medicine.